Elspeth Davies describes how living with an elevated risk of cancer damaged her relationship with her body, and how she ...

Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly ...

In this meta-analysis, researchers aimed to characterize the relationship between sentinel node biopsy and melanoma survival.

Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those predicted to have ...

Researchers studied incidence rates and temporal trends for cutaneous squamous cell carcinoma, cutaneous squamous cell carcinoma in situ, and keratoacanthoma.

A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...

Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...

Douglas Grossman, MD, Ph.D., co-leader of the Melanoma Center at Huntsman Cancer Institute at the University of Utah (the U) and professor of dermatology at the U, has helped develop a noninvasive ...

The new imaging system, a noninvasive technology, analyzes the expression of a protein in pigmented lesions that correlates with tumor development. The system accurately discerned the difference ...

(HealthDay News) — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, ...